Article Figures & Data
Figures
- Figure1
How NGS technology enables precision medicine in cancer.
Tables
Company Panel name Number of genes Coverage Note Life sciences Ion ampliSeq hotspot cancer panel 50 None indicated Compatible with FFPE sample Life sciences Ion ampliSeq comprehensive cancer panel 409 None indicated Detect CNV; compatible with FFPE sample Illumina TruSight cancer panel 94 20× Germline only Illumina TruSight tumor 15 panel 15 ≥500× Solid tumor somatic variants Illumina TruSight amplicon cancer panel 48 ~1000× Somatic mutational hotspots Illumina TruSight RNA pan-cancer panel 21,043 exonic region 3 million reads per sample Gene expression, variant and fusion detection in 1,385 cancer associated genes IDT xGen® pan-cancer panel 127 >97% of targeted covered at 30× Can be expanded by adding custom probes
